We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Amicus Therapeutics Inc is a biotechnology company focused on discovering, developing and delivering medicines for people living with rare metabolic diseases. The company is engaged in developing a pipeline of medicines for rare metabolic diseases, including a rare disease gene therapy portfolio. It... Amicus Therapeutics Inc is a biotechnology company focused on discovering, developing and delivering medicines for people living with rare metabolic diseases. The company is engaged in developing a pipeline of medicines for rare metabolic diseases, including a rare disease gene therapy portfolio. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. Show more
PRINCETON, N.J., March 20, 2024 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD), a patient-dedicated global biotechnology company focused on developing and commercializing novel medicines...
PRINCETON, N.J., March 01, 2024 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced that management will participate in upcoming presentations at the following investor...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -1 | -8.82612533098 | 11.33 | 11.41 | 10.32 | 2501177 | 10.69052149 | CS |
4 | -1.75 | -14.4867549669 | 12.08 | 12.24 | 10.32 | 2385020 | 11.3290091 | CS |
12 | -2.4 | -18.8531029065 | 12.73 | 14.03 | 10.32 | 3057128 | 12.39246436 | CS |
26 | -0.3 | -2.82220131703 | 10.63 | 14.57 | 9.7 | 3012928 | 12.19391388 | CS |
52 | -1.54 | -12.9738837405 | 11.87 | 14.57 | 9.7 | 2751815 | 12.25892263 | CS |
156 | 0.43 | 4.34343434343 | 9.9 | 14.57 | 5.91 | 2695060 | 10.92836029 | CS |
260 | -2.51 | -19.5482866044 | 12.84 | 25.39 | 5.91 | 2732590 | 11.60119493 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions